Research and startups are each important ingredients as the University of Maryland, Baltimore works to build a biotech community. In the case of recent news from KaloCyte, a mix involving both came with one move. As announced last week, the team that is commercializing a synthetic blood product relocated from St. Louis to downtown Baltimore, with the company taking up residence at UMB and joining the University of Maryland BioPark as an affiliate.
Image: The University of Maryland BioPark. (Courtesy photo)
{iframe}https://technical.ly/baltimore/2019/09/30/kalocyte-biotech-move-university-maryland-biopark/{/iframe}